With its ever-expanding legalization, marijuana has gained mainstream acceptance. But do we really know it’s safe? asks Hannah Wallace.
Last year, Oregon became the fourth state to legalize the recreational use of marijuana. In my hometown of Portland, people began lighting up on street corners, friends threw pot-themed dinner parties, and I heard whispers about a chef who hand-delivers salted caramel medibles (medical-cannabis edibles).
Whenever my husband, an unapologetic marijuana enthusiast, invites me to join him, I decline. Past experiments always gave me a sense of creeping agitation rather than euphoria. I struggle with insomnia, however, and my cocktail of remedies—valerian, wine, and Ambien—has become less and less reliable. Which is how I find myself one recent afternoon at Farma, a dispensary a mile from my house, admiring buds with names like Island Sweet Skunk and Dogwalker that are displayed beneath glass like so many exquisite chocolates. “I’m looking for something that will help me sleep—an indica?” I stammer, naming the strain that I’ve read delivers a calming high (another, sativa, has a reputation for working as a stimulant).
“We don’t classify cannabis that way,” my budtender, a slender young beauty, tells me crisply. “It’s the terpenes that are important.” Terpenes, she explains, are the aromatic oily compounds that confer character on each strain of marijuana and are believed to be responsible for particular effects. So while every label at Farma lists the percentages of tetrahydrocannabinol (THC), pot’s main psychoactive compound, and cannabidiol (CBD), the medicinal element that eases pain and anxiety but won’t get you high, terpenes are the ingredient of the moment. My attendant selects a glass jar and waves it under my nose. “I’d try Blueberry Malawi combined with Harlequin,” she cheerfully suggests.
This story is from the December 2016 edition of Vogue.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 2016 edition of Vogue.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
A Mother's Story
In a Broadway revival of Amy Herzog's play Mary Jane, Rachel McAdams finds uncommon grace in an account of parental struggle and pain.
Old Souls
A new production of Uncle Vanya brings the eternal wisdom of Anton Chekhov to the stage.
ELIZABETH DEBICKI
The actor who brought Princess Diana to life—and won a passel of awards in the process—is ready to transform anew.
If the Shoe Doesn't Fit
Forever looking for a 42 ina world of 39s.
Stuck on You
Once applied primarily to adolescent totems, stickers for wellness!are growing up.
Partial to It
Gen Zers have deemed side parts hopelessly outdated, but new defenders see the appeal.
With Nail and I
Inspired by recent runways, Lena Dunham tries on inch-long talons and mere tip-skimming lengths, and wonders: What do our nails say about all we’re asked to do?
Not Black and White
At just 27, Anna Park has made a major impression on the art world. Dodie Kazanjian visits her studio.
Prep School
Back in the '90s, Plum Sykes arrived in New York from London and promptly found herself in the thrall of preppy chic. Now, she writes, it's all coming back.
States of WONDER
John Galliano's recent Maison Margiela triumph was an haute couture tour de force. Yet, as Hamish Bowles recalls, it's but the latest in the designer's long history of era-defining shows.